Advertisement
+ News Categories + Corporate Categories + Report Categories

Evidence of 'God particle' found

20:39 EDT 1 Jul 2012 | R&D Magazine

Scientists at the world's biggest atom smasher plan to announce Wednesday that they have nearly confirmed the primary plank of a theory that could restructure the understanding of why matter has mass, which combines with gravity to give an object..

Related Biotechnology, Pharmaceutical and Healthcare News

Original Article: Evidence of 'God particle' found

NEXT ARTICLE

More From BioPortfolio on "Evidence of 'God particle' found"

Biotech & Healthcare Channels World News Life Science Events Corporate Database Market Reports Categories
Search BioPortfolio:

Clinical Trials - Daily Updated Database search the latest medical and pharmaceutical trials.

Drugs Database search our comprehensive database of prescription drugs.

Research Literature - Daily Updated Database search biomedical papers and journals.
Advertisement

News Quicklinks

Search Biotech, Medical and Healthcare News

Popular Biotech, Medical and Healthcare News

Biotech News by Article Type

Biotech News by Location

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

Advertisement

Searches Linking to this Story

god particle related to biotechnology, how god particle related to biotechnology, god particle, god particles related to biotechnology, god particles related to biotechnology, god particles related to biotechnology, god particles related to biotechnology, how was god particle found, How god particale related to bio technology

Latest Biotechnology, Pharmaceutical and Healthcare News

Perosphere Receives FDA IND Clearance to Initiate Clinical Investigations of the Safety and Efficacy of PER977 to Reverse the Activity of Anticoagulation Therapies including Factor Xa- and IIa-Inhibitors

EUCARF Seminar: Scientific advice, regulatory strategy and health technology assessment

Salix Pharmaceuticals Announces Statistically Significant Results for Budesonide Foam in the Treatment of Active Mild to Moderate Ulcerative Proctitis or Ulcerative Proctosigmoiditis in Two Pivotal Phase 3 Studies

Alkermes Announces Data on ALKS 5461 and ALKS 3831 to Be Presented at 53rd Annual NCDEU Meeting

Natus Files 2013 First Quarter Form 10-Q

First Healthcare Compliance Announces National Availability of Comprehensive Compliance Solution for Physician Practices

NanoViricides, Inc. Files Quarterly Report - Reports a Strong Cash Position Sufficient for Initial Clinical Trials of Its First Drug Candidate